Los Angeles Capital Management
MRSN

Los Angeles Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Los Angeles Capital Management’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-6,390
Closed -$228K – 1162
2024
Q4 		$228K Sell
6,390
-1,196
-16% -$61.9K ﹤0.01% 1017
2024
Q3 		$358K Buy
7,586
+569
+8% +$25.1K ﹤0.01% 955
2024
Q2 		$353K Sell
7,017
-870
-11% -$62.9K ﹤0.01% 960
2024
Q1 		$883K Sell
7,887
-12
-0.2% -$1.19K ﹤0.01% 728
2023
Q4 		$458K Hold
7,899
– – ﹤0.01% 897
2023
Q3 		$251K Buy
+7,899
New +$375K ﹤0.01% 1010
2023
Q2 		– Sell
-2,472
Closed -$254K – 1239
2023
Q1 		$254K Buy
2,472
+429
+21% +$60.2K ﹤0.01% 1065
2022
Q4 		$299K Sell
2,043
-2,458
-55% -$415K ﹤0.01% 1037
2022
Q3 		$761K Buy
+4,501
New +$731K ﹤0.01% 790
2020
Q3 		– Sell
-1,314
Closed -$768K – 1485
2020
Q2 		$768K Buy
1,314
+418
+47% +$143K ﹤0.01% 948
2020
Q1 		$131K Buy
+896
New +$157K ﹤0.01% 1266

Other funds holding MRSN

NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $12.3B AUM 37.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return